Daily brief
CAR-T insurance listings: payment is not guaranteed
The November 15 briefing reports two insurance listings in China and a proposed research center in Cairo.
By Medical2China · Video date
Three things to know
The video reports that JW Therapeutics’ relma-cel entered China’s basic medical insurance list. CARsgen’s satri-cel entered a separate commercial-insurance innovative drug list for selected patients with previously treated advanced gastric or gastroesophageal junction cancer.
Both listings are described as taking effect on January 1, 2027. A listing does not guarantee insurer payment or equivalent coverage for overseas patients.
Egyptian officials discussed Chinese medicine training and research. The Egyptian Chinese University outlined a specialized research center, but its budget and opening date remain unconfirmed.
This is a dated video briefing. Reports and availability may have changed since it was recorded; confirm current details before making plans.

